Antibody landscapes after influenza virus infection or vaccination. - Wikidata - awgldk - TriplyDB

Antibody landscapes after influenza virus infection or vaccination.

Antibody landscapes after influenza virus infection or vaccination.

http://www.wikidata.org/entity/Q34580640

about

Host Immunological Factors Enhancing Mortality of Young Adults during the 1918 Influenza Pandemic Serology in the 21st century: the molecular-level analysis of the serum antibody repertoire Influenza: from zoonosis to pandemic Incorporating structure context of HA protein to improve antigenicity calculation for influenza virus A/H3N2 Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins.Serial Vaccination and the Antigenic Distance Hypothesis: Effects on Influenza Vaccine Effectiveness During A(H3N2) Epidemics in Canada, 2010-2011 to 2014-2015.Identification of amino acid substitutions supporting antigenic change of influenza A(H1N1)pdm09 viruses.Substantial Influenza Vaccine Effectiveness in Households With Children During the 2013-2014 Influenza Season, When 2009 Pandemic Influenza A(H1N1) Virus Predominated Prior infection with influenza virus but not vaccination leaves a long-term immunological imprint that intensifies the protective efficacy of antigenically drifted vaccine strains Immunogenic Stimulus for Germline Precursors of Antibodies that Engage the Influenza Hemagglutinin Receptor-Binding Site.Deep Sequencing Reveals Potential Antigenic Variants at Low Frequencies in Influenza A Virus-Infected Humans.The global antigenic diversity of swine influenza A viruses.Multi-epitope Models Explain How Pre-existing Antibodies Affect the Generation of Broadly Protective Responses to Influenza Human Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax™ delta inulin adjuvant.Effect of Statin Use on Influenza Vaccine Effectiveness.Seasonal Influenza Vaccination of Children Induces Humoral and Cell-Mediated Immunity Beyond the Current Season: Cross-reactivity With Past and Future Strains.Immunity against influenza A(H1N1) infections is determined by age at the time of initial strain circulation.Analysis of Anti-Influenza Virus Neuraminidase Antibodies in Children, Adults, and the Elderly by ELISA and Enzyme Inhibition: Evidence for Original Antigenic Sin.Selective pre-priming of HA-specific CD4 T cells restores immunological reactivity to HA on heterosubtypic influenza infection.Estimating the life course of influenza A(H3N2) antibody responses from cross-sectional data.Competition between influenza A virus subtypes through heterosubtypic immunity modulates re-infection and antibody dynamics in the mallard duck Different Repeat Annual Influenza Vaccinations Improve the Antibody Response to Drifted Influenza Strains Computational Characterization of Transient Strain-Transcending Immunity against Influenza A.Multi-Dimensional Measurement of Antibody-Mediated Heterosubtypic Immunity to Influenza.Strategies to guide the antibody affinity maturation process Detailed Report on 2014/15 Influenza Virus Characteristics, and Estimates on Influenza Virus Vaccine Effectiveness from Austria's Sentinel Physician Surveillance Network.Antigenic Relationships among Human Pathogenic Orientia tsutsugamushi Isolates from Thailand Antigenic variability: Obstacles on the road to vaccines against traditionally difficult targets.H3N2 Mismatch of 2014-15 Northern Hemisphere Influenza Vaccines and Head-to-head Comparison between Human and Ferret Antisera derived Antigenic Maps Focused antibody response to influenza linked to antigenic drift Vaccination has minimal impact on the intrahost diversity of H3N2 influenza viruses.Human mobility and the spatial transmission of influenza in the United States.Antigenic Maps of Influenza A(H3N2) Produced With Human Antisera Obtained After Primary Infection Reticulate evolution is favored in influenza niche switching.Dengue viruses cluster antigenically but not as discrete serotypes Long-term adaptation of the influenza A virus by escaping cytotoxic T-cell recognition.The case test-negative design for studies of the effectiveness of influenza vaccine in inpatient settings.Neutralizing Antibody Responses to Antigenically Drifted Influenza A(H3N2) Viruses among Children and Adolescents following 2014-2015 Inactivated and Live Attenuated Influenza Vaccination.Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination.Is seasonal vaccination a contributing factor to the selection of influenza epidemic variants?

P2860

Q26782795-21246143-B457-4E35-AD31-38A84E741DDA Q26997997-B33791F9-62FC-4DE0-BF6C-5D3C9D6E9FFE Q28596741-222A8A56-7E1D-4CB6-823F-CE2B3A21ACC2 Q28831177-10669298-D7CF-42B9-A1F7-5C635253CAF6 Q30151352-3C455ADE-7731-443F-98D8-117B9D4777E7 Q30151372-09F6BFAE-B280-4635-AD95-F2E47C1E6E8A Q30370987-BC9345C0-386C-4F15-9D0D-554D3F7F259F Q30381731-4D1171D9-502D-4BAE-BC9F-64D6EBBB798C Q30382895-2DF358A9-73BA-4B04-8BFF-DC0B138D8CE1 Q30382955-B4278EC4-D123-45D8-B450-2E7E4C8B9A1D Q30383252-A3C37733-326F-4271-A701-55727EE7ED27 Q30387317-DE012526-E467-434C-ACFD-CDB8C81DDD79 Q30389700-9944A963-C8D7-4299-8894-5B59E9DF8300 Q30389743-727CD8A3-B82A-485A-ABC9-440F0D35B46F Q30391150-12BD5A8B-258E-4675-8864-E8EE0A630595 Q30392333-66A2FF87-36E1-4AD9-9AD9-8E35B0A23FDC Q30393540-D0DADBBF-86E5-40D7-95DD-EBB77E8F76F5 Q30400179-FE29F1FA-5C61-44CC-8809-48AD0EF4A662 Q30401866-C0721C05-73B7-4B86-B400-76C7FF4E1DDA Q30903230-62B8A485-A2E9-459F-B45E-56592CFF5DC7 Q33825695-718A86BA-0BE2-4842-929F-7FB775331A0E Q33899438-067078A5-4474-4596-9A27-F1FFA4D42970 Q35620267-A6A56553-914B-4439-8981-0448129F2840 Q35671981-F09452CF-3D91-468E-ADB6-139510FB5014 Q35685300-7A7F10FF-565E-4910-A25F-CC4CA2C270C8 Q35956533-BFEF1196-4184-4483-BC1F-8BBFA923240D Q36036198-74F55C31-3F19-4C1D-BBFE-9F8150383852 Q36050577-E1CC8C11-F87B-4626-B97B-F292B33D4683 Q36167993-FB5A6318-D7A4-4630-817F-58FC13A3FB4B Q36184767-068257BE-C3B5-4639-AC08-5C0889EA4E34 Q36265115-481890C7-3FC7-4A98-9CC3-E101D4B7C010 Q36276859-FCEB85B4-3761-4738-8185-DF2208B8CF05 Q36365301-14AC492A-9F63-42A2-BA5F-16E45FC2F61B Q36905061-7D11D9E3-2191-465E-B7D4-2D16EB7577B2 Q36926525-61D431B8-F5A2-4BB9-A426-8035CD656846 Q37257646-647CD557-FAE1-4405-9121-8B51564A06D1 Q37260000-8CEFD2CF-238C-4B49-A811-C956ACA7997C Q37311543-8501872B-9476-4478-93D9-B39303B21501 Q37635478-0E99DCA4-33D2-4D96-B04C-D54F90EAC739 Q38635123-46BA26B8-1F6C-4E88-BB73-BE3034BF285F

P2860

Antibody landscapes after influenza virus infection or vaccination.

http://www.wikidata.org/entity/Q34580640

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Antibody landscapes after influenza virus infection or vaccination.

@ast

Antibody landscapes after influenza virus infection or vaccination.

@en

Antibody landscapes after influenza virus infection or vaccination.

@nl

type

label

Antibody landscapes after influenza virus infection or vaccination.

@ast

Antibody landscapes after influenza virus infection or vaccination.

@en

Antibody landscapes after influenza virus infection or vaccination.

@nl

prefLabel

Antibody landscapes after influenza virus infection or vaccination.

@ast

Antibody landscapes after influenza virus infection or vaccination.

@en

Antibody landscapes after influenza virus infection or vaccination.

@nl

P1433

Q34580640-6EB41722-83B2-4A7A-9076-C149AD8966A6

P1476

Q34580640-E3537039-84A8-48D3-BD44-0901F536CE95

P2093

Q34580640-0B754A5C-8AF0-4064-BB49-9E69E93A8B45

Q34580640-175A0265-D308-4C5E-9081-93EBC63EF4F6

Q34580640-1DB4377D-07EE-46A5-8F88-3D6AFCC262C5

Q34580640-2FF9BA7A-E877-42F2-A0FE-852076634D7E

Q34580640-3913E42D-240A-454C-914A-8450A207D492

Q34580640-504D0B0D-699E-45DC-9B35-0AC14B11C31A

Q34580640-53515CC7-683C-4CF2-B815-14775BACA532

Q34580640-677A580C-BFE9-4A9A-AD21-5CA33DB28200

Q34580640-68A39A55-AFBD-4601-8710-3C2A0C550C03

Q34580640-69FF0456-5B64-488C-A4CD-F7E7EC8918B4

P2860

Q34580640-098338A0-7894-4F57-B6F6-8134691A7635

Q34580640-167901A0-531D-4D14-BFD1-3E73D7CD2263

Q34580640-19C7F11B-E5E0-4044-9E77-180ABF1E2415

Q34580640-1BD0B630-C8AF-471E-9757-C00A8038E143

Q34580640-1D69936D-28F2-4A69-9DFE-EDA709936680

Q34580640-1F2FA1E3-72A8-4C37-AA8C-7F04EBF02352

Q34580640-235F5E81-AE48-454E-AF8F-37E6FD04052E

Q34580640-285A677C-EB00-43A2-8087-2733B1E361ED

Q34580640-2A30BFE3-D2CF-4948-BC5B-A6FA35359A4E

Q34580640-3FFCDE69-A6C7-43A0-AFCB-09AB69900E3F

P304

Q34580640-C8C5AFC1-C9C2-4D7E-883A-66D152BF45B3

P31

Q34580640-25BB7BC7-3442-431A-B394-503F05CA2252

P356

Q34580640-0E5E68F6-F437-4CDB-88EC-3E3F47E96539

P407

Q34580640-1740C989-AC75-47D5-8A92-1D26E0E8720E

P433

Q34580640-B008D4FD-C477-4A61-A060-A9589933C270

P478

Q34580640-D437A317-D537-4195-9F63-00A0B6950AE6

P50

Q34580640-22D18174-3C10-4B5B-BB99-65EB4C5F44EE

Q34580640-601B9A0C-2F63-4633-9692-B80B0413358F

Q34580640-6EA4CD2E-9659-4A8A-9DE1-46C1E92CB09C

Q34580640-8DF8127D-4CFF-4618-8BA2-29F4B5DC7287

Q34580640-DABB4249-7AE8-41C0-8B81-9F7CC8031F10

Q34580640-F1484075-5DC0-4AAE-8741-88545868ED33

P577

Q34580640-B247CEA9-50ED-4A19-B086-0954BF23156D

P5875

Q34580640-C265F154-C88C-490D-ADD5-6D4B9DF5073C

P698

Q34580640-557DD3A2-235F-4413-8603-45F56351726D

P921

Q34580640-3245AE17-BB97-4046-A2AC-0AEE81CDB047

P932

Q34580640-90423038-D61E-4C5D-A93B-F282FB861283

P356

SCIENCE.1256427

P1433

P1476

Antibody landscapes after influenza virus infection or vaccination

@en

P2093

A D M E Osterhaus

http://www.w3.org/2001/XMLSchema#string

A Fox

http://www.w3.org/2001/XMLSchema#string

A Mosterin

http://www.w3.org/2001/XMLSchema#string

A Palache

http://www.w3.org/2001/XMLSchema#string

D J Smith

http://www.w3.org/2001/XMLSchema#string

E Skepner

http://www.w3.org/2001/XMLSchema#string

G F Rimmelzwaan

http://www.w3.org/2001/XMLSchema#string

G van der Net

http://www.w3.org/2001/XMLSchema#string

H F L Wertheim

http://www.w3.org/2001/XMLSchema#string

J C de Jong

http://www.w3.org/2001/XMLSchema#string

P2860

Rapid cloning of high-affinity human monoclonal antibodies against influenza virus

Positive Darwinian evolution in human influenza A viruses

Mapping the antigenic and genetic evolution of influenza virus

Neutralizing antibodies against previously encountered influenza virus strains increase over time: a longitudinal analysis.

Humans and ferrets with prior H1N1 influenza virus infections do not exhibit evidence of original antigenic sin after infection or vaccination with the 2009 pandemic H1N1 influenza virus

Prevalence of antibodies against seasonal influenza A and B viruses in children in Netherlands.

The epidemiology of interpandemic and pandemic influenza in Vietnam, 2007-2010: the Ha Nam household cohort study I

Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model.

Understanding original antigenic sin in influenza with a dynamical system

Evidence for antigenic seniority in influenza A (H3N2) antibody responses in southern China.

P304

996-1000

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCIENCE.1256427

http://www.w3.org/2001/XMLSchema#string

P407

P433

6212

http://www.w3.org/2001/XMLSchema#string

P478

346

http://www.w3.org/2001/XMLSchema#string

P50

Colin A Russell

P577

2014-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

268569483

http://www.w3.org/2001/XMLSchema#string

P698

25414313

http://www.w3.org/2001/XMLSchema#string

P921

P932

4246172

http://www.w3.org/2001/XMLSchema#string